CO4930267A1 - Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas - Google Patents

Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas

Info

Publication number
CO4930267A1
CO4930267A1 CO97074402A CO97074402A CO4930267A1 CO 4930267 A1 CO4930267 A1 CO 4930267A1 CO 97074402 A CO97074402 A CO 97074402A CO 97074402 A CO97074402 A CO 97074402A CO 4930267 A1 CO4930267 A1 CO 4930267A1
Authority
CO
Colombia
Prior art keywords
treatment
acetyl cysteine
compositions containing
chronic wounds
ulcers
Prior art date
Application number
CO97074402A
Other languages
English (en)
Inventor
Stephen Bloor
Original Assignee
Johnson Y Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Y Johnson Medical Ltd filed Critical Johnson Y Johnson Medical Ltd
Publication of CO4930267A1 publication Critical patent/CO4930267A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con composiciones en lasque se emplea cisteína de N-acetilo, o sus sales aprobadas farmacéuticamente o sus derivados, en un portador farmacéuticamente aceptable, útiles en el tratamiento o profilaxis de úlceras crónicas, úlceras venosas, úlceras diabéticas y decúbitos. Tales composiciones pueden presentarse en forma de ungüento para administración tópica o en otra forma para administración sistémica. Adicionalmente, dichas composiciones pueden aplicarse sobre o dentro del vendaje que cubre la herida.
CO97074402A 1996-12-20 1997-12-22 Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas CO4930267A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9626468A GB2320431B (en) 1996-12-20 1996-12-20 Compositions for the treatment of chronic wounds

Publications (1)

Publication Number Publication Date
CO4930267A1 true CO4930267A1 (es) 2000-06-27

Family

ID=10804743

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97074402A CO4930267A1 (es) 1996-12-20 1997-12-22 Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas

Country Status (11)

Country Link
US (1) US6166084A (es)
EP (1) EP0848951B1 (es)
JP (1) JPH10273438A (es)
AT (1) ATE234615T1 (es)
AU (1) AU726545B2 (es)
CA (1) CA2225202A1 (es)
CO (1) CO4930267A1 (es)
DE (1) DE69719931T2 (es)
GB (1) GB2320431B (es)
SG (1) SG63786A1 (es)
ZA (1) ZA9711467B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
EP1609468A3 (en) * 2000-11-22 2006-01-25 Rxkinetix, Inc. A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
DE10121255A1 (de) * 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
US7597911B2 (en) * 2001-08-16 2009-10-06 Curapharm, Inc. Method and composition for treatment of wounds and burns
SE522979C2 (sv) * 2002-07-03 2004-03-23 Moelnlycke Health Care Ab Sårförband innefattande en icke-enzymatisk antioxidant
US20060141015A1 (en) * 2004-12-07 2006-06-29 Centre Des Technologies Textiles Antimicrobial material
WO2007137000A2 (en) * 2006-05-16 2007-11-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Combination cancer chemotherapy
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US20090177133A1 (en) * 2008-01-04 2009-07-09 Kristine Kieswetter Reduced pressure dressing coated with biomolecules
WO2010014306A1 (en) * 2008-07-28 2010-02-04 Tyco Healthcare Group Lp Antimicrobial and anticoagulant compositions and methods
GB2470040A (en) 2009-05-06 2010-11-10 Systagenix Wound Man Ip Co Bv Wound dressing material comprising N-acetyl cysteine
EP2445483B1 (en) * 2009-06-25 2017-04-26 McCord, Darlene Topical compositions and methods for wound care
US8632512B2 (en) 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9999702B2 (en) 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP2397125A1 (en) 2010-06-15 2011-12-21 Histocell, S.L. Antioxidant composition
CN105457016B (zh) 2010-09-22 2022-06-24 科罗拉多大学董事会 Smad7的治疗应用
US8597264B2 (en) 2011-03-24 2013-12-03 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
WO2014138670A1 (en) 2013-03-08 2014-09-12 The Regents Of The University Of Colorado, A Body Corporate Ptd-smad7 therapeutics
US10792337B2 (en) 2013-03-15 2020-10-06 Kci Licensing, Inc. Wound healing compositions
CA2976096C (en) 2014-02-20 2023-03-14 University Of Notre Dame Du Lac Substituted 2-[(4-phenoxyphenyl)sulfonylmethyl]thiirane as selective matrix metalloproteinase inhibitors
US10357546B2 (en) 2014-09-19 2019-07-23 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
AU2015332556B2 (en) 2014-10-14 2021-04-29 Samuel Lynch Compositions for treating wounds
WO2018140383A1 (en) * 2017-01-24 2018-08-02 Leal Jesus N-acetyle cysteine based compositions
US10292998B1 (en) 2018-08-07 2019-05-21 Ahad Mahootchi Compositions and methods for prevention and treatment of eye infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154914A (en) * 1965-08-26 1969-06-11 Mead Johnson & Co Anti-Inflammatory Compositions and methods
ZA702518B (en) * 1969-04-18 1971-01-27 Bristol Myers Co Acetylcysteine for acne
US3749770A (en) * 1969-08-11 1973-07-31 Mead Johnson & Co Compositions containing zinc mercaptide n-acetylcysteine carboxylate salts
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
FR2519988B1 (fr) * 1982-01-20 1985-06-14 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
IT1194117B (it) * 1981-11-20 1988-09-14 Isnardi Pietro & C Spa Derivati salicilici di n-acetilcisteina
US4414387A (en) * 1982-05-13 1983-11-08 Renato Broggi Cephapirin acetylcysteinate having antibacterial activity
GB8517301D0 (en) * 1985-07-09 1985-08-14 Salim A S M Synergistic biologically active substances
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
AU7176094A (en) * 1993-06-18 1995-01-17 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis

Also Published As

Publication number Publication date
GB9626468D0 (en) 1997-02-05
JPH10273438A (ja) 1998-10-13
GB2320431B (en) 2000-08-30
ZA9711467B (en) 1999-09-20
GB2320431A8 (en) 1998-12-18
EP0848951A1 (en) 1998-06-24
DE69719931T2 (de) 2003-12-24
AU4838397A (en) 1998-06-25
DE69719931D1 (de) 2003-04-24
AU726545B2 (en) 2000-11-09
ATE234615T1 (de) 2003-04-15
SG63786A1 (en) 1999-03-30
US6166084A (en) 2000-12-26
CA2225202A1 (en) 1998-06-20
EP0848951B1 (en) 2003-03-19
GB2320431A (en) 1998-06-24

Similar Documents

Publication Publication Date Title
CO4930267A1 (es) Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DE69403656D1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
SE0102315D0 (sv) Compounds
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
CA2154572A1 (fr) Application du riluzole dans le traitement du neuro-sida
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
IT1231509B (it) Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ATE204752T1 (de) Therapeutische anwendungen von 2',5'- oligoadenylat-derivaten
ES2053161T3 (es) Composiciones antimicrobianas.
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
DK0495226T3 (da) Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
SE9602262D0 (sv) New use of derivatives of cystine
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
ES2126015T3 (es) Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas.
ATE339204T1 (de) Freisetzungsregulierende zubereitungen
DE68913997D1 (de) Fluorierte flavon-essigsäure.